Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 109
- Registration Number
- NCT00117962
- Locations
- 🇺🇸
Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, United States
🇺🇸Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia, United States
🇺🇸Missouri Cancer Associates, Columbia, Missouri, United States
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Conditions
- Large B Cell Lymphoma
- Interventions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2021-11-17
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 524
- Registration Number
- NCT00118209
- Locations
- 🇺🇸
Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
🇺🇸Charles R. Wood Cancer Center at Glens Falls Hospital, Glens Falls, New York, United States
🇺🇸Madigan Army Medical Center - Tacoma, Tacoma, Washington, United States
Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
- Conditions
- Breast Carcinoma
- Interventions
- Other: quality-of-life assessmentOther: Questionnaire Administration
- First Posted Date
- 2005-06-23
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 307
- Registration Number
- NCT00115505
- Locations
- 🇺🇸
CCOP - Duluth, Duluth, Minnesota, United States
🇺🇸Fletcher Allen Health Care - University Health Center Campus, Burlington, Vermont, United States
🇺🇸Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Fort Smith, Arkansas, United States
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2005-06-14
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 90
- Registration Number
- NCT00114231
- Locations
- 🇺🇸
Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa, Oklahoma, United States
🇺🇸Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸UPMC Cancer Center at Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2016-12-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 53
- Registration Number
- NCT00112528
- Locations
- 🇺🇸
Kapiolani Medical Center at Pali Momi, Aiea, Hawaii, United States
🇺🇸St. Mary-Corwin Regional Medical Center, Pueblo, Colorado, United States
🇺🇸Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Procedure: Computed Tomography-Guided Optical Sensor-Guided Radiofrequency Ablation
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 54
- Registration Number
- NCT00109876
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Stony Brook University Cancer Center, Stony Brook, New York, United States
Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Procedure: surgeryRadiation: brachytherapy
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2019-10-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 224
- Registration Number
- NCT00107172
- Locations
- 🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
🇺🇸Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸Evanston Hospital, Evanston, Illinois, United States
Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
- Conditions
- Breast CancerOsteoporosis
- Interventions
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 558
- Registration Number
- NCT00107263
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction
- Conditions
- Esophageal Cancer
- Interventions
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2016-12-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 37
- Registration Number
- NCT00107341
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 58
- Registration Number
- NCT00107510
- Locations
- 🇺🇸
Graham Hospital, Canton, Illinois, United States
🇺🇸Memorial Hospital, Carthage, Illinois, United States
🇺🇸McDonough District Hospital, Macomb, Illinois, United States